XIE Xuhua,WU Yun,HUANG Songqing,et al.Development and exploration of a closed-loop management model for externally dispensed intravenous prescriptions[J].ZHONGGUO YAOFANG,2026,37(10):1246-1250.
XIE Xuhua,WU Yun,HUANG Songqing,et al.Development and exploration of a closed-loop management model for externally dispensed intravenous prescriptions[J].ZHONGGUO YAOFANG,2026,37(10):1246-1250.DOI: 10.6039/j.issn.1001-0408.2026.10.02.
Development and exploration of a closed-loop management model for externally dispensed intravenous prescriptions
To construct a closed-loop management model for externally dispensed intravenous prescriptions, and to provide reference for standardized management of externally dispensed intravenous prescriptions.
METHODS
2
Based on the
Expert Consensus on Closed-loop Management of Externally Dispensed Intravenous Prescriptions in Guangxi Zhuang Autonomous Region
previously formulated by our hospital, risk points during the entire process were systematically identified through multidisciplinary team brainstorming and a fishbone diagram. A series of strategies were subsequently formulated and implemented, including qualifying designated external dispensing pharmacies and the drug catalogs, operating and maintaining the hospital information system and the Pharmacy Intravenous Admixture Service (PIVAS) intelligent management platform, and strengthening differentiated training for staff in the whole workflow. A whole-process closed-loop management system was constructed with PIVAS as the co
re hub and the daytime chemotherapy center as the safety terminal.
RESULTS
2
A total of 3 cooperating pharmacies and an initial drug list comprising 35 product specifications were selected. A closed‑loop management process encompassing hospital outpatient prescribing, patient drug purchase in designated pharmacies, PIVAS drug dispensing, and medication use in daytime chemotherapy center was successfully established. This system enabled the mandatory grouping and association of externally dispensed intravenous prescriptions with in-hospital diluents, full-process verification based on drug traceability codes, intelligent monitoring of infusion parameters, and whole-process data traceability.
CONCLUSIONS
2
The constructed model effectively resolves the coordination and safety oversight during the use of externally dispensed intravenous drugs from out-of-hospital circulation to in-hospital use, and has preliminarily enabled procedural standardization, whole-process information traceability, and proactive control of medication risks.